Evidence map›Paper›PMID 42474794›Full record

ArticleJournal of robotic surgery2026

Management of thymic epithelial tumors more than 5 cm with subxiphoid robotic thymectomy: perioperative and mid-term outcomes.

Fuqiang Wang, Hanlu Zhang, Xiaoli Mei, Zhiyang Li, Guanghao Qiu, Xuyang Wang, Zhangyi Dai, Jiajun Cheng, Lei Peng, Yun Wang

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Fuqiang WangDepartment of Thoracic Surgery, West China Hospital, Sichuan University, Sichuan, 610041, China.
Hanlu ZhangDepartment of Thoracic Surgery, West China Hospital, Sichuan University, Sichuan, 610041, China.
Xiaoli MeiDepartment of Thoracic Surgery, West China Hospital, Sichuan University, Sichuan, 610041, China.
Zhiyang LiDepartment of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Guanghao QiuCenter of Gerontology and Geriatrics, Laboratory of Metabolism and Aging Research, State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, National Clinical Research Center for Geriatrics, Sichuan University, Chengdu, China.
Xuyang WangDepartment of Thoracic Surgery, West China Hospital, Sichuan University, Sichuan, 610041, China.
Zhangyi DaiDepartment of Thoracic Surgery, West China Hospital, Sichuan University, Sichuan, 610041, China.
Jiajun ChengDepartment of Thoracic Surgery, West China Hospital, Sichuan University, Sichuan, 610041, China.
Lei PengLung Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Yun WangDepartment of Thoracic Surgery, West China Hospital, Sichuan University, Sichuan, 610041, China. yunwwang@yeah.net.

Funding

Sichuan Science and Technology Program 2025ZNSFSC1717
6 · The paper itself

Abstract

To assess feasibility and oncological results of subxiphoid robotic thymectomy by comparing perioperative and survival outcomes between large (≥ 5 cm) and small (< 5 cm) thymic epithelial tumors (TETs). This retrospective research contained 145 patients with TETs undergoing subxiphoid robotic thymectomy between September 2016 and November 2022. Patients were assigned into large and small tumor group according to maximum diameter on chest CT. The large and small tumor groups included 51 and 94 patients respectively. All patients underwent R0 resection. Patients with large tumor group had prolonged surgical time (135 vs. 120 min, p = 0.005). Other characteristics including pathology, length of hospital stay, TNM stage and tumor invasion were not significantly different between groups. Median follow-up was 65 months. 62.8% of patients completed 5 years of follow-up. Five-year FFR (85.2% vs. 93.4%, p = 0.18), OS (92.6% vs. 95.5%, p = 0.75), and DFS (85.2% vs. 89.9%, p = 0.61) were comparable between large and small tumor groups. In contrast, FFR differed significantly by histotype (p = 0.0001). Among patients undergoing subxiphoid robotic thymectomy, there is no significant differences in survival outcomes over 5 years between large and small tumors.

Indexed as

Neoplasms, Glandular and EpithelialRobotic Surgical ProceduresThymectomyThymus NeoplasmsAdultAgedFeasibility StudiesFemaleFollow-Up StudiesHumansMaleMiddle AgedOperative TimeRetrospective StudiesTreatment OutcomeMinimally invasive surgeryRobot-assisted thymectomyThymic epithelial tumorsTumor size

Identifiers

PMID42474794

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.